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Abstract
 
The intestinal mucosa is suggested to support extrathymic T cell development, particularly for
 
T cell receptor (TCR)-
 
gd
 
 intraepithelial lymphocytes (IELs). TCR-
 
gd
 
 cell development re-
 
quires interleukin (IL)-7; IL-7
 
2
 
/
 
2
 
 or IL-7 receptor
 
2
 
/
 
2
 
 mice lack TCR-
 
gd
 
 cells. Using the in-
testinal fatty acid binding protein (iFABP) promoter, we reinstated expression of IL-7 to ma-
ture enterocytes of IL-7
 
2
 
/
 
2
 
 mice (iFABP-IL7). In iFABP-IL7 mice, TCR-
 
gd
 
 IELs were
restored, as were cryptopatches and Peyer’s patches. TCR-
 
gd
 
 cells remained absent from all
other tissues. Likewise, T cell development in thymus and B cell maturation in the bone mar-
row and spleen retained the IL-7
 
2
 
/
 
2
 
 phenotype. Thus, IL-7 expression by enterocytes was suf-
ficient for extrathymic development of TCR-
 
gd
 
 cells in situ within the intestinal epithelium
and was crucial for organization of mucosal lymphoid tissue.
Key words: immunology • cell differentiation • morphogenesis • germinal center
 
Introduction
 
The concept of extrathymic T lymphocyte development
predicts that T cell progenitors and all factors required for
their maturation are present at extrathymic sites. One factor
known to be requisite for development of TCR-
 
gd
 
 cells is
the cytokine IL-7. In mice lacking IL-7, IL-7 receptor (IL-
7R
 
a
 
 or 
 
g
 
c
 
 chain), or the 
 
g
 
c
 
 signal transduction molecule
Janus kinase (JAK)3, neither thymic nor extrathymic
TCR-
 
gd
 
 cells are produced (1–6). The intestinal mucosa
has been suggested to support extrathymic T cell develop-
ment, particularly for TCR-
 
gd
 
 intraepithelial lymphocytes
(IELs)
 
1
 
 (7–13). This hypothesis is supported by demonstra-
tions that intestinal epithelial cells express stem cell factor
(SCF) (14, 15) and IL-7 (16–18), cytokines that together
are essential for intrathymic T cell development (19).
Moreover, anatomical structures in the intestinal mucosa,
 
termed cryptopatches, have been described that contain
 
T-committed lymphocyte precursors expressing the receptors
for SCF (c-Kit, CD117) and IL-7 (IL-7R
 
a
 
, CD127) (20).
 
Transplantation of cryptopatch cells from 
 
nu/nu
 
 mice into
SCID recipients generates small numbers of TCR-
 
gd
 
 IELs
and TCR-
 
ab
 
 cells in the IEL and mesenteric lymph node
compartments (21). However, since cryptopatches were
transplanted to euthymic mice, it remains unclear whether
the progeny of cryptopatch cells were derived via a bona
fide process of extrathymic T cell development.
We have recently shown that extrathymic IL-7 expres-
sion is sufficient to promote development of TCR-
 
gd
 
 IELs
in thymectomized, irradiated, bone marrow–reconstituted
(ATxBM) chimeric mice (6). However, in that model sys-
tem (and all other models of extrathymic T cell develop-
ment), IL-7 is produced at sites other than the intestinal ep-
ithelium, most notably in the bone marrow (22), a known
lymphopoietic organ. For this reason, it has been impossi-
 
ble to unequivocally identify the site of extrathymic TCR-
 
gd
 
cell development. To circumvent this problem, we re-
stored IL-7 expression to the intestinal epithelium of IL-
7
 
2
 
/
 
2 
 
mice using the tissue-specific intestinal fatty acid bind-
ing protein (iFABP) promoter. This model has allowed us
to isolate the functional consequences of IL-7 production
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by intestinal epithelial cells from those that would normally
occur in concert with IL-7–mediated hematopoiesis at
other sites. Profound changes in intestinal T and B lympho-
cytes were induced by the IL-7 produced in the intestine, in-
cluding restoration of TCR-
 
gd
 
 IELs and augmentation of
cryptopatch and Peyer’s patch assembly. These findings
support the concept that a subset of TCR-
 
gd
 
 IELs devel-
ops completely within the intestines of normal mice. In ad-
dition, it is likely that intestine-produced IL-7 is involved
in the recruitment or proliferation of lymphoid progenitors
that establish the pattern of cryptopatch and Peyer’s patch
formation.
 
Materials and Methods
 
Generation of iFABP-IL7 Transgenic Mice.
 
A plasmid containing
the cDNA encoding IL-7 (reference 23; obtained from R. Mur-
ray and U. von Freeden-Jeffry, DNAX Research Institute of Cel-
lular and Molecular Biology, Palo Alto, CA) was digested with
XhoI. The 0.5-kb fragment containing the IL-7 cDNA was puri-
fied and BamHI sites introduced into the 5
 
9
 
 and 3
 
9
 
 ends by PCR
using Taq DNA polymerase (Life Technologies). The sense
primer was 5
 
9
 
-GGGGGATCCATGTTCCATGTTTCTTTT-
AGA-3
 
9
 
, and the antisense primer was 5
 
9
 
-GGGGGATCCT-
TATATACTGCCCTTCAAAAT-3
 
9
 
, obtained from Life Tech-
nologies. The correct PCR product was resolved by PAGE, and
the ends of the DNA were filled in using the Klenow fragment of
DNA polymerase (Roche Molecular Biochemicals). BamHI-
restricted IL-7 cDNA (nucleotides 548 to 1,012; reference 23)
was ligated into the expression vector, pIH, that had been linearized
with BamHI. The plasmid contained the bacterial origin of repli-
cation and 
 
amp
 
r
 
 genes from the 2.9-kb SalI fragment derived from
pSG5 (Stratagene, Inc.), the iFABP promoter (nucleotides 
 
2
 
1178
to 
 
1
 
28; a gift of J.I. Gordon, Washington University School of
Medicine, St. Louis, MO; references 24 and 25), and hGH (nu-
cleotides 498 to 2,652; a gift of R.M. Perlmutter, University of
Washington, Seattle, WA; reference 26). The orientation of the
cDNA and its complete sequence as well as the sequences of the
eukaryotic control elements were verified. The SalI linear 3.9-kb
fragment of pIH-IL7 was purified and microinjected into fertil-
ized eggs obtained from IL-7
 
2
 
/
 
2
 
 mice. IL-7
 
2
 
/
 
2
 
 mice were origi-
nally obtained from R. Murray and U. von Freeden-Jeffry and
were maintained on a C57BL/6J 
 
3 
 
129 Ola hybrid background,
as previously described (27). All mice were fed sterile food and
water and were housed in microisolators under specific patho-
gen–free conditions. Their welfare was in accordance with insti-
tutional and Office of Laboratory Animal Welfare guidelines.
 
Southern Blotting.
 
Screening of iFABP-IL7 transgenic mice
was by Southern blot. Approximately 10 
 
m
 
g of genomic DNA
(prepared from 0.25 inch of tail) was digested with PstI (Life
Technologies) and electrophoresed in a 0.8% Seakem
 
®
 
 Gold aga-
rose gel (FMC Bioproducts). The DNA was transferred by capil-
lary action to a NYTRAN
 
®
 
 membrane (0.45 
 
m
 
m, net neutral
charge; Schleicher & Schuell, Inc.) in 10
 
3
 
 SSPE (1.5 M NaCl,
100 mM NaH
 
2
 
PO
 
4
 
, 12.5 mM EDTA, pH 7.4). DNA was UV
cross-linked to the membrane (2,400 J) and incubated at 45
 
8
 
C
with a probe containing the last 1,300 bp of hGH in 5 ml of hy-
bridization buffer (0.1 M Tris-HCl, 5 mM EDTA, 0.5 mg/ml
heparin, 0.1% sodium pyrophosphate, 0.5% sarcosyl, 10% dextran
sulfate, 1 M NaCl, 30% formamide, and 0.1 mg/ml sheared
salmon sperm, pH 7.5). DNA (
 
z
 
25 ng) was labeled with
 
a
 
-[
 
32
 
P]dATP (Amersham Life Science) using a Random Primers
DNA Labeling System (Life Technologies). Excess, unincorpo-
rated 
 
a
 
-[
 
32
 
P]dATP was removed by filtration through a G-50
Sephadex Quick Spin column (Boehringer Mannheim). The
specific activity of the probe was 1–3 
 
3
 
 10
 
9
 
 counts per minute
per microgram.
In some cases, mice were screened by dot blot instead of
Southern blot. In those cases, 
 
z
 
10 
 
m
 
g of genomic DNA was de-
natured in 0.3 M NaOH at 65
 
8
 
C for 
 
z
 
1.5 h. NaOH was neu-
tralized by adding an equal volume of 12
 
3
 
 SSC, and then serial
twofold dilutions of the DNA were blotted to a NYTRAN
 
®
 
membrane using a MilliBlot-D dot blotting system (Millipore
Corp.). Membranes were UV cross-linked and hybridized using
the hGH probe as described above.
All blots were washed in 2
 
3
 
 SSC for 15 min at room temper-
ature, followed by one 30-min and then one 20-min wash in
0.1
 
3
 
 SSC 
 
1
 
 0.2% SDS at 65
 
8
 
C. Bands were visualized by ex-
posing membranes to Biomax MS film (Eastman Kodak Co.) for
 
.
 
5 h with a BioMax TranScreen-HE intensifying screen (East-
man Kodak Co.).
 
RNase Protection.
 
Entire organs were used to obtain tissue for
preparation of RNA. For example, the entire thymus or intestine
(duodenum, jejunum, or ileum [24]) was frozen in liquid nitro-
gen and pulverized to a powder (using a Bessman tissue pulver-
izer; Fisher Scientific). Bone marrow was aspirated using a 26-
gauge needle and subjected to centrifugation to concentrate cell
aggregates. RNA was isolated from powdered tissues or bone
marrow plugs using guanidinium isothiocyanate and cesium
chloride gradient centrifugation (28). Typically, 20 
 
m
 
g of RNA
from each tissue was used for RNase protection experiments us-
ing a RiboQuant
 
®
 
 multiprobe RNase protection assay system and
the mCK-4 template set (PharMingen). RNA (2.5 
 
m
 
g) purified
from T220 cells (3T3 cell line stably transfected with the IL-7
cDNA [29]; provided by H.H. Wortis, Tufts University School
of Medicine, Boston, MA) served as the positive control for
mRNA encoding IL-7 and SCF in RNase protection experiments.
 
Lymphocyte Isolation.
 
Lymphocytes were isolated from thymi,
spleens, lymph nodes, and Peyer’s patches using a glass homoge-
nizer and then passed through 100-
 
m
 
m NITEX nylon mesh
(Tetko) to remove connective tissue. Splenic RBCs were lysed
via two sequential incubations in Tris-ammonium chloride (13
mM Tris, 135 mM NH
 
4
 
Cl, pH 7.2) for 4 min at 37
 
8
 
C. Before
staining for flow cytometric analyses, splenocyte FcRs were pre-
blocked with affinity-purified mouse IgG (200 
 
m
 
g/ml; Jackson
ImmunoResearch Labs., Inc.).
IELs were isolated from the small intestine (gastroduodenal
junction to the ileocecal junction) essentially as previously de-
scribed (30). In brief, intestines were cut longitudinally and then
into 5-mm pieces and washed twice with CMF (Ca
 
2
 
1
 
, Mg
 
2
 
1
 
-free
HBSS with 1 mM Hepes, 2.5 mM NaHCO
 
3
 
, pH 7.3) containing
2% FCS. Washed intestinal pieces were combined and stirred at
37
 
8
 
C for 20 min in CMF containing 10% FCS and 1 mM dithio-
erythritol (Calbiochem Corp.). This step was repeated, and the
cells in the supernatants from both treatments were combined
and rapidly filtered through scrubbed nylon wool (NEN™).
Cells were then subjected to centrifugation on a 44/67.5% Per-
coll (Pharmacia) gradient. Viable cells at the interface were col-
lected and prepared for flow cytometric analyses.
Lamina propria (LP) lymphocytes were isolated using a modi-
fied version of the protocols published by Poussier et al. (12) and
Kramer and Cebra (31). After IEL isolation, the remaining epi-
thelial cells were removed by stirring the intestinal pieces in 1.3
mM EDTA in Ca
 
2
 
1
 
, Mg
 
2
 
1
 
-free HBSS at 37
 
8
 
C for 30 min. This 
1571
 
Laky et al.
 
was repeated, and both supernatants were discarded. Gut pieces
were then stirred in RPMI 1640 media containing 5% FCS at
22
 
8
 
C for 20 min until clear, and any released cells were discarded.
The complete integrity of the villi and crypts and the absence of
epithelial cells at this stage of the cell isolation was confirmed his-
tologically. After this, LP lymphocytes were released from the tis-
sue by digestion with 100 U/ml collagenase (Life Technologies)
in RPMI supplemented with 1 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
, and
5% FCS at 37
 
8
 
C for 30 min. Collagenase treatment was repeated.
Cells released after each treatment were combined, washed in
PBS containing 5% FCS, and then subjected to Percoll fraction-
ation as described above for isolation of IELs.
 
Visualization of Dendritic Epidermal T Cells.
 
Dendritic epider-
mal T cell (DETC) sheets were isolated for whole mount staining
as previously described (32, 33). In brief, abdominal and back
skin was shaven with a straight razor and then cut into 2.5-cm2
pieces. Pieces were incubated for 2–4 h in EDTA buffer (116
mM NaCl, 2.6 mM KCl, 8 mM Na2HPO4, 1.4 mM KH2PO4,
20 mM EDTA, pH 7.3) in a 5% CO2 incubator at 378C. The
epidermis was then peeled off of each piece using fine forceps.
Epidermal sheets were fixed in 238C acetone for 20 min and then
washed three times in PBS on ice for a total of 30 min. Fixed
sheets were incubated overnight at 48C with biotinylated anti-
CD3e (34) diluted in PBS 1 0.2% Tween 20 and then washed
three times in PBS–Tween for a total of 1.5 h. Biotinylated mAbs
were visualized by incubating stained sheets with streptavidin–
Texas Red (Jackson ImmunoResearch Labs., Inc.) for 1 h at
378C, followed by three washes in 13 PBS–Tween as above.
Stained epidermal sheets were examined and photographed using
a Nikon Optiphot microscope.
mAbs. The following mAbs were used: anti-CD3e–FITC
(145-2C11; reference 34) or anti-CD3e–biotin (500A2); anti-
TCR-gd–PE or –biotin (GL3; reference 35); anti-TCR-gd
(3A10; reference 36); anti-TCRVg5 (GL1; reference 35); anti-
Vg2–FITC or –biotin (UC3-10A6); anti-TCRVg1 (2.11), a gift
from P. Pereira (Institut Pasteur, Paris, France) (37); anti-
TCRVd4–FITC (GL2; reference 35); anti-TCRab–FITC, –Cy-
Chrome, or –PE (H57.597); anti-B220 (RA3-6B2)–Cy-Chrome;
anti-IgM–FITC or –biotin (Kirkegaard & Perry Labs.); unconju-
gated anti-IgD or anti-IgD–FITC; anti-IgA–biotin (Kirkegaard &
Perry Labs.); anti-CD38 (90)–PE; anti-GL7; peanut agglutinin
(PNA; Vector Labs.); anti–c-Kit (ACK2; reference 38), a gift
from S.-I. Nishikawa (Kyoto University, Kyoto, Japan); irrele-
vant rat IgG2b, k (R35–38); and rabbit anti–rat IgG–biotin (Vec-
tor Labs.). All mAbs were obtained from PharMingen unless oth-
erwise noted. Biotin-conjugated antibodies were visualized with
streptavidin–PE or –Cy5 (Jackson ImmunoResearch Labs., Inc.).
Immunofluorescence Analyses. A single-cell suspension of lym-
phocytes in PBS containing 0.2% BSA and 0.1% NaN3 (PBS/
BSA/NaN3) was incubated with 100 ml of properly diluted mAb at
48C for 15 min. After staining, cells were washed twice with PBS/
BSA/NaN3, and relative fluorescence intensities were measured by
fluorescence flow cytometry using a FACSCalibur™ (Becton
Dickinson). Fluorescence intensity is presented on a four-decade
log scale. A minimum of 10,000 cells within the forward versus
side scatter lymphocyte gate were analyzed in each sample.
Immunohistochemical Analyses. Small intestines were cut first
into 1–1.5-cm pieces and then slit open longitudinally along the
mesenteric side. Intestinal pieces were placed villus side up, and a
square of filter paper was placed on top. The intestine and filter
paper were placed into a no. 3 cryodish (EXCEL BRAND) filter
paper side up and then covered with O.C.T. freezing media (Tis-
sue Tek; Miles, Inc.). The entire dish was then submerged in
hexane that had been chilled to 2708C in a dry ice/acetone bath.
Specimens were stored at 2808C until sectioning.
Intestines were cut into 5-mm-thick sections with a cryostat,
placed on poly-l-lysine glass slides, and allowed to air dry. Slides
were stored at 2208C until staining. Just before staining, sections
were fixed in acetone. For cryptopatch staining, intestinal sec-
tions were incubated with Block-ase (Dainippon Pharmaceutical
Co., Ltd.) for 10 min at 378C to block nonspecific binding sites.
All sections were incubated with properly diluted primary anti-
body for 30 min and then washed three times with PBS. Sections
were then incubated with biotinylated goat anti–rat IgG (Cedar-
lane Labs.), biotinylated rabbit anti–rat IgG (Vector Labs.), or bi-
otinylated goat anti–hamster IgG (Vector Labs.) and then washed
three times with PBS. Sections were then incubated with avidin–
biotin peroxidase complexes (Vectastain ABC kit; Vector Labs.).
Antibodies were visualized by Vectastain DAB (3,39-diami-
nobenzidine) substrate kit (Vector Labs.) according to manufac-
turer’s instructions.
Statistical Analyses. All analyses were two-tailed Student’s t tests
conducted using InStat Instant Biostatistics (GraphPad Software).
Results
Restoration of Typical TCR-gd IEL IL-72/2 Mice by an
iFABP-IL7 Transgene. Four lines of IL-72/2 mice contain-
ing IL-7 cDNA driven by the iFABP promoter were estab-
lished (iFABP-IL7). The iFABP promoter directs constitu-
tive expression of transgenes to mature villus-associated
enterocytes but not to crypt epithelial cells beginning at
zE16 and continuing throughout life. In addition, the
iFABP promoter regulates mRNA and protein expression
along the longitudinal axis of the intestine, with highest lev-
els in the jejunum and ileum and lower levels in the duode-
num and proximal colon (24, 25). The pattern of ex-
pression of the IL-7 transgene in iFABP-IL7 mice was
demonstrated by RNase protection (Fig. 1). As expected,
IL-7 mRNA was detected in the bone marrow, thymi, and
small intestines of IL-71/1 mice, albeit at different levels,
and was absent from all tissues in IL-72/2 mice. In iFABP-
IL7 mice, IL-7 mRNA was present in the small intestine
but not in the bone marrow or thymus. Similar to other
transgenes expressed using this promoter system, the highest
levels of IL-7 mRNA were present in the jejunum and il-
eum, with lower levels in the duodenums of transgenic
mice (Fig. 1, right panel). This was true for both lines of
iFABP-IL7 mice tested. The amount of IL-7 mRNA
present in iFABP-IL7 intestine resembled the amount of
IL-7 mRNA present in the intestines of IL-71/1 mice, both
being much lower than the amount present in the thymi of
control IL-71/1 mice. Also notable was that the levels of
mRNA encoding SCF were characteristic for each tissue
examined and unaffected by the levels of mRNA encoding
IL-7. The appearance of iFABP-IL7 transgenic mice was
indistinguishable from their nontransgenic littermates, with
no evidence of runting, alopecia, or rectal prolapse. This
was in contrast to other lines of IL-7 transgenic mice,
which overexpress IL-7 in wild-type IL-71/1 mice (17, 39).
Thus, the iFABP-IL7 transgene approximated normal IL-7
production within the intestine.1572 IL-7–dependent Lymphocyte Development within the Intestine
As previously reported (2), small intestinal TCR-gd IELs
are absent from nontransgenic littermate control IL-72/2
mice. In contrast, expression of IL-7 under control of the
iFABP promoter induced development of TCR-gd IELs
localized in the small intestinal epithelium, as demonstrated
by immunohistochemistry and fluorescence flow cytomet-
ric analysis of lymphocytes after isolation (Fig. 2, A and B).
The percentage and number of TCR-gd IELs in transgenic
mice was consistently less than that of age-matched IL-71/1
mice, ranging from 4 to 19% of CD31 small intestinal IELs
as compared with 18 to 32% in wild-type mice. Similar re-
sults were obtained in two other lines of iFABP-IL7 trans-
genic mice (data not shown).
TCR-gd IELs present in iFABP-IL7 mice appeared de-
velopmentally normal based on phenotypic analysis. The
pattern of TCR expression was characterized on TCR-gd
IELs (Fig. 2 C). The majority of TCR-gd cells in iFABP-
IL7 mice expressed TCRVg5, TCRVd4, or TCRVg1,
prominent V regions of small intestine IELs expressed by
normal mice, including the IL-71/1 line of control mice
(references 30, 37, 40, 41, and data not shown). TCR-gd
IELs were also uniformly CD8a1 and expressed high levels
of the mucosal integrin aE (data not shown).
Restoration of Cryptopatches by an iFABP-IL7 Transgene.
Cryptopatches are tiny clusters of z1,000 c-Kit1IL-
7R1Thy-11Lineage2 cells located in the LP of the murine
small intestine (20, 21). Cryptopatches, a potential source
of extrathymic IEL precursors, are severely reduced in IL-
7Ra2/2 mice (20), suggesting that their formation is de-
pendent on IL-7. The presence of cryptopatches in IL-72/2
mice had not been evaluated. Therefore, we looked for
cryptopatches in IL-71/1, IL-72/2, and iFABP-IL7 mice
(Fig. 3). Similar to other strains of mice, IL-71/1 mice
(C57BL/6 3 129 Ola hybrid background) had z1,500
large clusters of c-Kit1 cells along the length of the small in-
testine. In contrast, the small intestines of IL-72/2 mice had
only z30 very small clusters of c-Kit1 cells. This was con-
sistent with the paucity of cryptopatches in IL-7Ra2/2
mice and reemphasized the importance of IL-7 signaling in
cryptopatch formation. The small intestines of iFABP-IL7
mice had z750 cryptopatches of intermediate size. The re-
duced level of cryptopatches and TCR-gd cells may be due
to the fact that the iFABP promoter directs transgene ex-
pression to mature enterocytes and not crypt epithelial cells
(25). Thus, the local concentration of IL-7 in iFABP-IL7
cryptopatches would be less than in wild-type mice, in
which IL-7 is thought to also be expressed by crypt epithe-
lial cells (42). Therefore, in iFABP-IL7 mice, the level of
restoration of cryptopatches correlates with the level of
TCR-gd IEL production.
Restoration of Lymphocyte Development Exclusively in the In-
testine in iFABP-IL7 Mice. Interestingly, in the intestinal
Figure 1. Pattern of expression of
IL-7 mRNA in iFABP-IL7 mice.
RNase protection analysis of expres-
sion of IL-7 mRNA in transgenic
and nontransgenic mice. RNA was
prepared from the entire organs of
the tissues indicated. 20 mg of RNA
from each tissue was used for RNase
protection experiments using a Ri-
boQuant® multiprobe RNase pro-
tection assay system and the mCK-4
template set (PharMingen). RNA
purified from T220 cells (2.5 mg)
served as the positive control for
mRNA encoding IL-7 and SCF.
Left panel: note the presence of IL-7
mRNA in the jejunum (J) of the in-
testine, but not in the bone marrow
(B) or thymus (T) of iFABP-IL7
mice. IL-7 mRNA was absent from
all tissues in IL-72/2 mice. Two far
left lanes represent mRNA protected
in 40 mg of bone marrow (B) RNA
from wild-type (1) or iFABP-IL7
(Tg) mice. The pattern of expression
of mRNA was representative of
three to five individual mice ana-
lyzed for each genotype. Right
panel: the expression of IL-7 mRNA
in the intestine of transgenic mice
was concentrated in the jejunum (J)
and ileum (I), with lower levels of
expression in the duodenum (D).
Expression of endogenous SCF was
uniform throughout the length of
the intestine and irrespective of ex-
pression of IL-7.1573 Laky et al.
mucosa of iFABP-IL7 mice, TCR-gd cell development
was restricted to the epithelium. Although a detectable
population of TCR-gd cells was present in the LP of the
small intestines of IL-71/1 mice, no TCR-gd cells were
found in the LP of IL-72/2 mice or of iFABP-IL7 trans-
genic mice (Fig. 4 A). This result indicated that the IL-7
produced by villus enterocytes was unable to direct TCR-
gd cell development in the LP, either due to a deficiency
in T cell precursors able to mature within that site or to the
limited range of cytokine action. Moreover, transgenic ex-
pression of IL-7 did not restore thymic or splenic TCR-gd
cell populations (Fig. 4 A), nor did iFABP-IL7 restore nor-
mal TCR-ab thymocyte development. Compared with
IL-71/1 mice, the number of total thymocytes and splenic
T cells in IL-72/2 animals are reduced 40- and 20-fold, re-
spectively (27). These values were unaffected by the pres-
ence of the iFABP-IL7 transgene (data not shown).
Skin-resident TCR-gd IELs (DETCs) were absent from
adult iFABP-IL7 transgenic mice, as they were from IL-72/2
mice (Fig. 4 A). Control IL-71/1 mice had 404 6 25
CD3e1 DETCs per square millimeter. It is known that
most, if not all, adult DETCs are the progeny of intrathy-
mic precursors that arise during fetal life (43, 44). Therefore,
since DETCs were completely absent from iFABP-IL7
mice, the existence of intestinal TCR-gd IELs in trans-
genic mice cannot be the result of IL-7 production by
undifferentiated epithelial cell progenitors in the embryo.
Thus, when considered with the data presented in Figs. 2
and 3, iFABP-IL7 mice provide the first example of ex-
trathymic T cell development, in situ, within the intestine.
In the absence of IL-7, the number of lymphocytes in
bone marrow is greatly reduced, and the ability of B cell
precursors to mature from pro- to pre-B cells is impaired
(27). Unlike other IL-7 transgenic mice that overexpress IL-7
in the bone marrow (45, 46), the IL-72/2 bone marrow
phenotype was maintained in iFABP-IL7 animals (Fig. 4 B).
Bone marrow mononuclear cells from IL-72/2 or iFABP-
IL7 mice contained ,10% lymphocytes, compared with
.25% in IL-71/1 mice. Moreover, IL-72/2 and iFABP-IL7
mice had reduced percentages of pre-B, immature, and ma-
ture B cells. Thus, the number of pre- and immature B cells
was not elevated in iFABP-IL7 mice. This was an indication
that IL-7 produced by enterocytes in the intestine had no
effect on lymphopoiesis in bone marrow.
In the spleen, the absolute numbers of B cells isolated
from iFABP-IL7 and nontransgenic IL-72/2 littermates
were not different (z106), and both were z20-fold less
Figure 2. Restoration of typical TCR-gd IELs in iFABP-IL7 mice.
(A) Frozen sections of small intestinal villi from IL-72/2 (left), iFABP-IL7
(center), and IL-71/1 (right) mice were stained with mAb specific for
TCR-gd as described in Materials and Methods. Note the complete ab-
sence of TCR-gd cells from IL-72/2 mice and partial restoration of
TCR-gd cells to iFABP-IL7 mice. (B) Small intestinal IELs were isolated
from IL-72/2, iFABP-IL7, or age-matched IL-71/1 control animals. The
cells were stained with mAb directed against CD3e, TCR-ab, and
TCR-gd  and then analyzed by fluorescence flow cytometry. CD3e1 cells
within the forward versus side scatter lymphocyte gate were analyzed for
TCR expression. The numbers indicate the percentage of TCR-gd1 cells
among total CD3e1 cells. (C) Small intestinal IELs from iFABP-IL7 mice
were stained with mAb directed against either TCR-gd, TCRVg5, and
TCRVg2 or TCRVg1 or CD3e, TCR-ab, TCRVg5, and TCRVd4.
The numbers reflect the percentage of the indicated TCRVg1 cells
among total TCR-gd cells. Since antibodies directed against all TCR-gd
and TCRVd4 compete for binding, CD3e1TCRab2 IELs were posi-
tively gated and analyzed for expression of TCRVg5 and TCRVd4.
Figure 3. Restoration of cryp-
topatches in iFABP-IL7 mice.
6-mm frozen sections of small in-
testine crypts from IL-72/2 (left),
iFABP-IL7 (center), and IL-71/1
(right) mice were stained with
mAb specific for c-Kit as de-
scribed in Materials and Meth-
ods. The cryptopatches shown
typify those seen along the
length of the intestine and are
representative of at least three
mice studied for each of the in-
dicated genotypes. Note the in-
termediate number of c-Kit1
cells in cryptopatches from
iFABP-IL7 mice.1574 IL-7–dependent Lymphocyte Development within the Intestine
intestines of iFABP-IL7 mice. It was originally presumed that
the B2201IgM1IgD2 and B2201IgM2IgD2 splenocytes in
IL-72/2 animals were abnormal populations of immature B
cells (27). Interestingly, our further analyses confirmed this
was true only for a subset of these B lymphocytes. The
B2201IgM1IgD2 cells were a mixture of immature transi-
Figure 4. Intestinal epithelium–specific effects of the iFABP-IL7 trans-
gene. (A) Lymphocytes prepared from the small intestine LP, thymus, or
spleen were stained with mAb against CD3e, TCR-ab, and TCR-gd.
CD3e1 lymphocytes were positively gated and then analyzed for TCR-ab
and -gd expression. The numbers indicate the percentage of TCR-gd1
cells among total CD3e1 cells. Epidermal sheets prepared from skin of 8.5-
wk-old mice were stained with biotinylated anti-CD3e, followed by
streptavidin–Texas Red, and visualized by immunofluorescence micros-
copy. It was striking that TCR-gd cells were restored exclusively to the
intestinal epithelium of iFABP-IL7 mice and were completely absent even
from small intestinal LP. (B) B cells isolated from iFABP-IL7 bone marrow
or spleen were compared with B cells isolated from age-matched IL-72/2
or IL-71/1 control mice. Bone marrow cells were stained with anti-B220
and -IgM and then analyzed by fluorescence flow cytometry (top). Cells
within the lymphocyte gate were analyzed to determine the relative per-
centages of cells within each of the B cell maturation stages defined by Hardy et al. (74). The numbers indicate the percentage of cells in each subset
among total lymphocytes. Splenocytes were stained with anti-B220, -CD3, -IgM, and -IgD. CD32B2201 B cells were positively gated and then ana-
lyzed for surface Ig expression (bottom). The numbers indicate the percentage of B cells in each quadrant of the phenotype indicated. No changes in the
distribution of mature T (A) or B lymphocytes (B) were noted between IL-72/2 mice or iFABP-IL7 mice outside of the intestinal epithelium.
than that found in IL-71/1 mice. Moreover, the unique
populations of B2201IgM1IgD2 and B2201IgM2IgD2
splenocytes present in IL-72/2 animals were maintained in
transgenic mice (Fig. 4 B). The failure of the iFABP-IL7
transgene to restore normal splenic B cell populations was
further evidence that the action of IL-7 was confined to the
Figure 5. Restoration of Peyer’s patches in iFABP-IL7
mice. Ileal Peyer’s patches were dissected from the small intes-
tines of IL-72/2 (a), iFABP-IL7 (b), or age-matched IL-71/1
control mice (c). 5-mm paraffin sections were stained with he-
matoxylin and eosin. Note that the small intestinal ileal Peyer’s
patches from iFABP-IL7 animals were larger than those of IL-
72/2 littermates but smaller than those of age-matched IL-71/1
control mice. Scale bar, 100 mm.1575 Laky et al.
tional B cells, being CD38highHSAhighPNAlowCD62L2, and
marginal zone B cells, being HSAlowCD211CD232CD11
(47, 48). The absolute number of cells in each B cell subset
did not exceed the numbers found in IL-71/1 mice (data
not shown). The unique population of B2201IgM2IgD2
cells in the spleens of IL-72/2 mice (both transgenic and
nontransgenic) contained CD38lowHSAhighPNAhighGL71
and IgG1 cells visualized by flow cytometric and immuno-
histochemical analyses (data not shown), suggesting that
impaired B cell development, in both bone marrow and
the periphery of IL-72/2 mice, resulted in more prominent
populations of germinal center and memory B cells (49).
Restoration of Peyer’s Patches by an iFABP-IL7 Trans-
gene. Macroscopic examination of the small intestines of
iFABP-IL7 mice revealed a prominent effect of the trans-
gene on Peyer’s patches. In contrast to the minimal Peyer’s
patch development in IL-72/2 mice (27), there were pro-
found increases in the size and number of Peyer’s patches
in transgenic mice with IL-7 produced by mature entero-
cytes, cells that comprise 90% of the surface area of the fol-
licle-associated epithelium (50). Histological analyses indi-
cated that in iFABP-IL7 mice, Peyer’s patches were up to
fourfold larger than those found in IL-72/2 mice (Fig. 5).
In IL-71/1 mice, 6–10 Peyer’s patches were found at rela-
tively constant locations along the antimesenteric side of
the small intestine, concentrated in the jejunum and ileum
(Table I). Only small ileal Peyer’s patches were consistently
detected in IL-72/2 animals. In contrast, there was a signif-
icant increase in the number of visible ileal and jejunal
Peyer’s patches in iFABP-IL7 mice. In IL-71/1 mice, a sin-
gle Peyer’s patch was always observed in the area of the
duodenal–jejunal border, and this Peyer’s patch was not
restored by the transgene. The regional localization of
Peyer’s patches in iFABP-IL7 mice paralleled the pattern of
expression of IL-7 in the intestine (Fig. 1, right panel).
Peyer’s Patches in iFABP-IL7 Mice Had Increased Germinal
Center B Cells. Restoration of Peyer’s patches in iFABP-
IL7 mice was not due to increased B cell development in
bone marrow (Fig. 4 B), suggesting that the effect of IL-7
on Peyer’s patches occurred directly within Peyer’s patches
in iFABP-IL7 mice. Thus, we examined the phenotype
of lymphocytes present in Peyer’s patches from IL-72/2,
iFABP-IL7, or IL-71/1 mice. No differences were noted in
the distribution of CD41 or CD81 T cell subsets (data not
shown). Interestingly, among Peyer’s patch B lymphocytes,
IL-72/2 and iFABP-IL7 animals had at least fivefold higher
percentages of CD38lowIgA1HSAhighPNAhighCD22low cells
as compared with IL-71/1 animals (Fig. 6 and data not
shown). IL-72/2 and iFABP-IL7 animals also had increased
percentages of CD38lowIgA1 cells in LP (data not shown).
These data indicated that the ability to form germinal cen-
ters and to undergo Ig class switch recombination was not
impaired in Peyer’s patches in IL-72/2 mice.
The relative percentage of naive and germinal center B
cells was altered in iFABP-IL7 mice (Fig. 6). Thus, we
sought to determine whether the architecture of Peyer’s
patches in iFABP-IL7 mice was normal. Immunohistochem-
ical analyses of frozen sections revealed that the overall
Table I. Regional Distribution of Small Intestinal Peyer’s Patches
Mouse Duodenum Jejunum Ileum
IL-72/2
0, 0, 0, 0, 0, 0, 0, 0,
0, 0, 0, 0, 0, 0, 0
0, 0, 0, 0, 0, 0, 0, 0,
0, 0, 0, 1, 1, 1, 2*
0, 1, 1, 2, 2, 2, 2, 2,
2, 2, 2, 2, 2, 3, 3*
iFABP-IL7 0, 0, 0, 0, 0 0, 1, 2, 2, 2 2, 2, 3, 3, 4
IL-71/1
1, 1, 1, 1, 1
1, 1, 1, 1*
2, 2, 2, 3, 4
4, 4, 5, 5*
2, 2, 3, 3, 3
3, 4, 4, 4
Two-tailed unpaired Student’s t tests were performed to compare the numbers of Peyer’s patches in different regions of small intestine from 4–9-wk-
old IL-72/2, iFABP-IL7, and age-matched IL-71/1 control mice.
*Significantly different than iFABP-IL7 transgenic animals (P , 0.01).
Figure 6. B lymphocyte maturation in Peyer’s patches in iFABP-IL7
mice. Peyer’s patch lymphocytes were prepared as described in Materials
and Methods and then stained with anti-B220, -CD38, and -IgA or PNA
and analyzed by flow cytometry. B2201 cells were positively gated and
then analyzed for level of CD38 expression and cell surface IgA (top).
The numbers indicate the percentage of B2201 cells that fell within each
quadrant. The CD38highIgA2 cells in the lower right quadrant were IgM1
(data not shown). B2201CD38high or B2201CD38low cells were positively
gated and then analyzed for their ability to bind PNA (bottom). The per-
centages of PNA1 cells among total B2201 cells are indicated.1576 IL-7–dependent Lymphocyte Development within the Intestine
iFABP-IL7 animals. Intestinal epithelial cells normally ex-
press IL-7 (Fig. 1 and reference 16–18), and TCR-gd cells
were reconstituted solely within the intestinal epithelium of
iFABP-IL7 IL-72/2 mice. Thus, iFABP-IL7 mice are an ex-
traordinary model system for studying normal extrathymic
TCR-gd cell development in vivo, without extensive and
invasive experimental manipulation, i.e., irradiation, thymec-
tomy, or intravenous transfer of hematopoietic precursors.
Because the expression and action of IL-7 in iFABP-IL7 an-
imals was exquisitely regulated, this is the first model system
that allows the extrathymic site of TCR-gd cell develop-
ment to be precisely identified. De novo generation of
TCR-gd IELs in iFABP-IL7 mice indicated that all IL-7–
dependent steps of T cell development occurred within the
intestine, including commitment to the TCR-gd cell lin-
eage. It is agreed that IL-7R signaling influences TCR-g
gene rearrangement (52–55) or expression of TCRVg genes
(56–62). Since signaling through IL-7R promotes TCR-g
gene rearrangement and/or transcription, then IL-7 pro-
duced within the intestine provided the stimulus to initiate
extrathymic development of TCR-gd cells. Also present
Figure 7. Visualization of germinal centers in
iFABP-IL7 Peyer’s patches. Peyer’s patches were
dissected from the small intestine of age-matched
control IL-71/1 mice (top) or iFABP-IL7 mice
(bottom). 6-mm frozen sections were stained as de-
scribed in Materials and Methods with mAbs that
identified total B cells (B2201), total T cells
(CD31), naive B cells (IgD1), or germinal center B
cells (GL71). The iFABP transgene restored germi-
nal centers to approximately the size visualized in
normal mice, despite the concurrent deficiency in
naive B cells.
structure of Peyer’s patches was the same in adult iFABP-
IL7 and IL-71/1 mice (Fig. 7). The spatial distribution of T
cells (CD31), B cells (B2201), and marginal zone macro-
phages (MOMA-11; data not shown) did not differ between
iFABP-IL7 and IL-71/1 mice. However, there was a strik-
ing difference in the phenotype of B lineage cells. Consis-
tent with previous reports (49, 51), the majority of B cells
in Peyer’s patches from IL-71/1 mice were naive IgD1 B
cells. In contrast, GL71 germinal center B cells accounted
for a very large percentage of total Peyer’s patch volume in
Peyer’s patches from iFABP-IL7 mice, with far fewer IgD1
cells. These results, taken together with the flow cytometry
data presented in Fig. 6 and macroscopic observations that
similar numbers of follicles were visualized in each Peyer’s
patch present in iFABP-IL7 mice, suggest that intestinal IL-7
promotes organogenesis of Peyer’s patches in normal mice.
Discussion
Our results provide compelling evidence for extrathymic
development of TCR-gd IELs in situ, within the intestine of1577 Laky et al.
within the intestine were lymphoid progenitors that re-
sponded to IL-7, as well as other growth factors (e.g., SCF)
required for homeostasis of mature TCR-gd IELs.
The reduced number of TCR-gd IELs in iFABP-IL7
mice was not surprising, as these mice lack thymus-derived
mature TCR-gd IELs, which comprise a subset of IELs in
normal mice (6, 63). Moreover, IL-72/2 mice appear to have
reduced numbers of extrathymic T cell progenitors (6, 20)
that were only partially restored in iFABP-IL7 mice. In nor-
mal mice, cryptopatches are not detected until after birth, but
then they are maintained throughout their lifespans. Crypto-
patches are rare in IL-7Ra2/2 mice (20). This suggests that
cryptopatches are colonized with progenitor cells from bone
marrow and then are either self-renewing or continuously
replenished from IL-7–dependent hematopoiesis in bone
marrow, which was not restored in iFABP-IL7 mice. Despite
this, the concomitant restoration of TCR-gd IELs and intes-
tinal cryptopatches in iFABP-IL7 mice supports the hypoth-
esis that cryptopatches contain extrathymic IEL precursors.
The RNase protection assay used to verify the tissue-spe-
cific expression of transgenic IL-7 allowed simultaneous vi-
sualization of multiple cytokine mRNAs. Thus, the relative
amounts of growth factor mRNAs were compared within
individual samples. IL-7 and SCF are two cytokines critical
for normal thymic (19) and extrathymic T cell development
(our unpublished results). We and others have shown that
stromal cells in bone marrow, thymus, and intestine express
IL-7 and SCF mRNA (14, 16, 18, 42, 64–66). However,
the relative levels of these two cytokines in each lym-
phopoietic site had not been evaluated. The RNase protec-
tion data in Fig. 1 clearly showed that the relative levels of
IL-7 and SCF mRNA were inverse in the thymus and in-
testine in control IL-71/1 mice. In the thymus, mRNA en-
coding IL-7 was greater than that encoding SCF, whereas
in the intestine, mRNA encoding SCF was greater than
that encoding IL-7. This pattern of mRNA expression was
not unique to this strain of mice, as it was also observed in
C57BL/6J and WCB6F1 wild-type mice (data not shown).
The significance of this finding to thymic and extrathymic
T cell development is not yet clear. However, it is notable
that most TCR-gd thymocytes in adult mice express IL-7Ra,
whereas most TCR-gd IELs express c-Kit (6) and prolifer-
ate in response to SCF production in vivo (15).
The effect of IL-7 on Peyer’s patch development further
emphasized the critical role for IL-7 in ontogeny of the
mucosal immune system. It has been reported that IL-7Ra
and JAK3 are required for the formation of the fetal Peyer’s
patch anlage (67). Our data showed that in adult IL-72/2
mice, limited Peyer’s patch formation occurred in the ab-
sence of IL-7, but transgene-directed IL-7 expression by villus
enterocytes increased the number of Peyer’s patches formed
and increased their size. Germinal center formation in Peyer’s
patches was not compromised in the absence of IL-7. In
fact, the opposite result was obtained whereby the fraction
of B cells in germinal centers (CD32B2201CD38lowPNA1GL71)
was increased without IL-7. Thus, the lack of active germi-
nal centers in gc
2/2 mice cannot be attributed to the ab-
sence of IL-7R signaling (1). Compatible with this is the
observation that another cytokine that utilizes the gc recep-
tor, IL-4, is critical for germinal center formation in the in-
testinal mucosa (68).
The paucity of naive B cells (IgD1 cells) in Peyer’s
patches of iFABP-IL7 mice (Fig. 7) was consistent with the
IL-7 deficiency outside of the intestine, a consequence of
decreased de novo development of B cells in bone marrow
(27). Thus, the increased size and number of Peyer’s
patches in iFABP-IL7 mice suggested that IL-7 influenced
B cell maturation within the intestine. IL-7 may have di-
rectly affected Peyer’s patch B cells by supporting de novo
B cell development within Peyer’s patches, as occurs in
sheep (69). Alternatively, IL-7 production by Peyer’s patch
follicle-associated epithelium may have facilitated entry of
the small number of bone marrow–derived transitional B
cells to the recirculating pool within Peyer’s patches or
augmented their proliferation in situ. Although it is be-
lieved that in normal mice most transitional B cells enter
the recirculating pool in the spleen (47, 48, 70), asplenic
Hox112/2 mice have normal B cell profiles in lymph node
and peripheral blood and demonstrate robust Ig responses
after immunization. This indicates that the final stages of B
cell maturation can occur outside of spleen (71, 72). In-
deed, the naive B cells in the Peyer’s patches of iFABP-IL7
mice may represent the normal contribution of Peyer’s
patch–derived IL-7 to the process of B cell selection.
Another possibility was that enterocyte-produced IL-7
affected B cell development indirectly, by influencing other
cell types that then affected B cells within Peyer’s patches.
For example, iFABP-IL7 may have augmented T helper
function or IL-4 production. Alternatively, intestinal IL-7
may have enhanced the development/recruitment of IL-
7Ra1 stromal elements or lymphoid cell progenitors in-
volved in Peyer’s patch formation and structure, as occurs
during assembly of the murine fetal Peyer’s patch anlage
(67, 73). This transgenic model is currently being exploited
in experiments designed to resolve these issues. It is clear
that iFABP-IL7 mice will provide a powerful tool for de-
fining the role of IL-7 in Peyer’s patch development and
more generally in B cell maturation.
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